SCHEMBL31108646

SCHEMBL31108646

COC(=O)c1c(Oc2cccc(Br)c2)ccc2[nH]ccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.45
▸ NR4A2 P43354 1/20 0.44
▸ CYP1A2 P05177 4/20 0.43
▸ GAA P10253 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ RECQL P46063 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ HSD17B10 Q99714 1/20 0.42
▸ CYP2C9 P11712 3/20 0.42
▸ CYP2C19 P33261 3/20 0.42
▸ NPSR1 Q6W5P4 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42
▸ CYP2D6 P10635 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ RHEB Q15382 2/20 0.41
▸ BRAF P15056 1/20 0.39
▸ MEN1 O00255 1/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ ALOX12 P18054 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29337712 0.87 L3MBTL1 (0.44) MAPTKDM4EHSD17B10RHEBMEN1
SCHEMBL30285551 0.87 L3MBTL1 (0.44) MAPTKDM4EHSD17B10RHEBMEN1
SCHEMBL29337679 0.83 BRD4 (0.44) KDM4EHSD17B10RHEBEGFR
SCHEMBL30217170 0.83 BRD4 (0.44) KDM4EHSD17B10RHEBEGFR
SCHEMBL29338295 0.83 KDM4E (0.40) NR4A2MAPTKDM4EHSD17B10RHEB
SCHEMBL29336710 0.82 F10 (0.45) KDM4EHSD17B10
SCHEMBL29338529 0.82 TUBB4A (0.39) NR4A2MAPTKDM4EHSD17B10RHEB
SCHEMBL30285558 0.82 TUBB4A (0.39) NR4A2MAPTKDM4EHSD17B10RHEB
SCHEMBL29338297 0.81 KDM4E (0.38) GAAMAPTKDM4EHSD17B10RHEB
SCHEMBL29336928 0.80 F10 (0.40) GAAMAPTKDM4EHSD17B10RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240279220-A1 INDOLE COMPOUNDS AND METHODS OF USE SIONNA THERAPEUTICS INC. 2024-08-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240279220-A1 INDOLE COMPOUNDS AND METHODS OF USE CFTR, INMT, IDO1 ALOX5 486/4885NR4A2 4135/4885CYP1A2 501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback